Co-Diagnostics (CODX)

• Market cap: $20.7M
• 1 day: -2.26%
• 5 days: -18.41%
• 1 month: 254.09%
• 3 months: 73.77%
• 6 months: -49.91%
• Year to date: 1.26%
• 1 year: -38.34%
• 5 years: -97.85%
• 10 years: -96.77%
• Sector: Healthcare
• Industry: Medical Devices

About: Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Employees: 115